Insider Trading History of Goldberg Michael M

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Goldberg Michael M since 2007. The trader's CIK number is 905011. At the time of the last reporting, Goldberg Michael M was the Director of Navidea Biopharmaceuticals, Inc.. (stock ticker symbol NAVB). Also see all insider trading activities at Navidea Biopharmaceuticals, Inc..

Note that in the past GOLDBERG MICHAEL M also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Emisphere Technologies Inc (EMIS) by Goldberg Michael M

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2007 EMIS 99,246 $0 0 $0 0 $0

Yearly summary of insider trading at Navidea Biopharmaceuticals, Inc. (NAVB) by Goldberg Michael M

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2014 NAVB 100,000 $107,770 0 $0 0 $0

Yearly summary of insider trading at Alliqua, Inc. (ALQA.OB) by Goldberg Michael M

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2012 ALQA.OB 2,000,000 $0 0 $0 0 $0


Insider trading activities at 3 companies by Goldberg Michael M:

1. Emisphere Technologies Inc (EMIS)

2. Navidea Biopharmaceuticals, Inc. (NAVB)

3. Alliqua, Inc. (ALQA.OB)

Table 1. Insider trading of Emisphere Technologies Inc (EMIS) by Goldberg Michael M

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2007-08-22 EMIS Buy 99,246 .00 0

Table 2. Insider trading of Navidea Biopharmaceuticals, Inc. (NAVB) by Goldberg Michael M

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2014-11-14 NAVB Buy 28,359 1.12 31,903
2014-11-13 NAVB Buy 71,641 1.06 75,867

Table 3. Insider trading of Alliqua, Inc. (ALQA.OB) by Goldberg Michael M

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2012-02-16 ALQA.OB Buy 2,000,000 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Goldberg Michael M (Director of Navidea Biopharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.